While DHT is most prominently linked to prostate cancer, there is ongoing research investigating its role in other cancers, including breast cancer and bladder cancer. The precise mechanisms are not yet fully understood, but it is hypothesized that DHT may influence cancer through its interaction with androgen receptors in various tissues.
